Personnel Information

写真a

TABATA Koichi


Job title

Assistant Professor

Field Introduction URL

Department of Psychiatry and Behavioral Sciences, Institute of Science Tokyo

To the head of this page.▲

Graduating School 【 display / non-display 】

  • University of Yamanashi, Faculty of Medicine, 2016.03, Graduated

To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2017.04
    -
    2018.03
    Tokyo Medical and Dental University， (Old Organization)Medical Hospital， Central Clinical Facilities， Professional Development Center， Trainee Resident
  • 2020.10
    -
    2021.03
    Tokyo Medical and Dental University， (Old Organization)Medical Hospital， Hospital Departments， Department of Neurology, Neurosurgery,Psychiatry and Anesthesiology， Psychiatry， Resident
  • 2021.04
    -
    2024.09
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Division of Cognitive and Behavioral Medicine， Department of Psychiatry and Behavioral Sciences， Graduate Student
  • 2024.10
    -
    2025.03
    Institute of Science Tokyo， -， Graduate Schools， Cognitive and Behavioral Medicine， Department of Psychiatry and Behavioral Sciences， Graduate Student
  • 2025.04
    -
    2026.03
    Institute of Science Tokyo， -， Institute of Science Tokyo Hospital， Department of Neurology, Neurosurgery, Psychiatry, and Anesthesiology， Psychiatry， Project Assistant Professor
  • 2026.04
    -
    Now
    Institute of Science Tokyo， -， Graduate Schools， Endowed Departments， -， Assistant Professor

▼display all

To the head of this page.▲

External Career 【 display / non-display 】

  • 2016.04
    -
    2017.03
    , Trainee Resident
  • 2018.04
    -
    2020.03
    , Resident
  • 2020.04
    -
    2020.09
    , Resident
  • 2021.04
    -
    2021.12
    Tokyo Metropolitan Institute of Medical Science, Schizophrenia Research Project, Researcher
  • 2022.01
    -
    2024.09
    Tokyo Metropolitan Institute of Medical Science, Schizophrenia Research Project, Researcher
  • 2026.04
    -
    Now
    Niigata Psychiatric Center, Department of Psychiatry, Psychiatrist

▼display all

To the head of this page.▲

Academic Society Affiliations 【 display / non-display 】

  • Japanese Society of General Hospital Psychiatry

  • Japanese Society of Schizophrenia Research

  • The Japanese Society of Psychiatry and Neurology

  • The Japanese Society for Prevention and Early Intervention in Psychiatry

  • Japanese Society of Biological Psychiatry

  • The Japanese Biochemical Society

  • Japan Society for Biomedical Research on Trace Elements

  • Japanese Society for Zinc Nutritional Therapy

  • Japan Human Brain Mapping Society

▼display all

To the head of this page.▲

Research Areas 【 display / non-display 】

  • Psychiatry

  • Neuroscience-general

To the head of this page.▲

Qualification Acquired 【 display / non-display 】

  • Doctor

To the head of this page.▲
 

Research Theme 【 display / non-display 】

  • Efficacy of Zinc Supplementation for Schizophrenia with Hypozincemia: A Randomized, Double-Blind, Placebo-Controlled Trial, 2026.05 - 2029.03

  • Retrospective investigation of perinatal environmental exposures associated with schizophrenia risk using shed deciduous teeth, 2024.04 - 2027.03

To the head of this page.▲

Published Papers & Misc 【 display / non-display 】

  1. Iino, K; Toriumi, K; Miyashita, M; Suzuki, K; Tabata, K; Miyata, S; Takahashi, M; Fujii, J; Itokawa, M; Arai, M. Pentosidine accumulation induced by Akr1a deficiency drives aggression and hyperactivity NEUROSCIENCE LETTERS. 2026.02; 877 138557. ( PubMed, DOI )

  2. Tabata, K; Toriumi, K; Suzuki, K; Takagi, H; Parida, IS; Niizato, K; Oshima, K; Imai, A; Nagase, Y; Hashimoto, R; Yamasaki, S; Nishida, A; Itokawa, M; Takahashi, H; Miyashita, M; Arai, M. Schizophrenia with hypozincemia: Clinical features and symptom severity SCHIZOPHRENIA RESEARCH. 2025.10; 286 9-15. ( PubMed, DOI )

  3. Toriumi, K; Miyashita, M; Yamasaki, S; Suzuki, K; Tabata, K; Yamaguchi, S; Usami, S; Itokawa, M; Nishida, A; Kamiguchi, H; Arai, M. Association between plasma glucuronic acid levels and clinical features in schizophrenia BJPSYCH OPEN. 2025.03; 11 (3): e77. ( PubMed, DOI )

  4. Tabata, K; Son, S; Miyata, J; Toriumi, K; Miyashita, M; Suzuki, K; Itokawa, M; Takahashi, H; Murai, T; Arai, M. Association of homocysteine with white matter dysconnectivity in schizophrenia SCHIZOPHRENIA. 2024.03; 10 (1): 39. ( PubMed, DOI )

  5. Cannabinoid CB2 receptors and hypersensitivity to methamphetamine: Vulnerability to schizophrenia. 2023.12; 110924. ( PubMed, DOI )

  6. Tomita, Y; Suzuki, K; Yamasaki, S; Toriumi, K; Miyashita, M; Ando, S; Endo, K; Yoshikawa, A; Tabata, K; Usami, S; Hiraiwa-Hasegawa, M; Itokawa, M; Kawaji, H; Kasai, K; Nishida, A; Arai, M. Urinary exosomal microRNAs as predictive biomarkers for persistent psychotic-like experiences SCHIZOPHRENIA. 2023.03; 9 (1): 14. ( PubMed, DOI )

  7. Toriumi, K; Miyashita, M; Suzuki, K; Tabata, K; Horiuchi, Y; Ishida, H; Itokawa, M; Arai, M. Role of glyoxalase 1 in methylglyoxal detoxification-the broad player of psychiatric disorders REDOX BIOLOGY. 2022.02; 49 102222. ( PubMed, DOI )

  8. Neuronal cell adhesion molecule regulating neural systems underlying addiction. 2019.03; 39 (1): 10-16. ( PubMed, DOI )

  9. Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders. 2018.07; 23 (8): ( PubMed, DOI )

▼display all

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  1. Hypozincemia is associated with clinical severities of schizophrenia. 2024.11.14

  2. Deciduous teeth are novel biosamples reflecting perinatal accumulation of AGEs and are predictive of psychotic symptoms during adolescence: a preliminary study. 2024.09.18

  3. Deciduous teeth are novel biosamples reflecting perinatal accumulation of AGEs and are predictive of psychotic symptoms during adolescence: a preliminary study. 2024.07.24

  4. Hypozincemia is associated with clinical severities of schizophrenia. 2023.09.01

  5. Environmental stressors on cannabinoid CB2 receptor dysfunction induce various psychosis. 2019.10.11

To the head of this page.▲

Awards & Honors 【 display / non-display 】

  • Academic Society Award (Medical Field)，Japanese Society of Schizophrenia Research，2026.03

  • Young Investigator Award，Japanese Society of Biological Psychiatry，2025.11

  • International Conference Presentation Encouragement Award，Japanese Society of Biological Psychiatry，2025.11

  • Psychiatry and Neurology Encouragement Award，Alumni Association of the Department of Psychiatry, Institute of Science，2025.06

  • International Conference Presentation Encouragement Award，Japanese Society of Schizophrenia Research，2025.04

  • International Conference Presentation Encouragement Award，Japanese Maillard Reaction Society，2024.10

  • Best Excellent Presentation Award，Japanese Society for Zinc Nutritional Therapy，2024.08

  • Excellent Presentation Award，Japan Society for Biomedical Research on Trace Elements，2023.09

  • Excellent Presentation Award，Japanese Society of Biological Psychiatry，2022.11

  • Young Investigator Award，Japan Human Brain Mapping Society，2022.02

  • Excellent Presentation Award，The Japanese Society of Psychiatry and Neurology，2018.06

▼display all

To the head of this page.▲